Physician profile
William E Royster
NPI 1598798621
$224.05
in general payments reported to CMS, 2019-2025
12 companies · $21.93 in 2025
The $21.93 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $44.75 · 2022: $21.46 · 2024: $33.55 · 2025: $21.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| My01 INC. | $33.55 | 2024 | My01 Continuous Compartmental Pressure Monitor |
| Pfizer INC. | $27.47 | 2019-2020 | |
| Dexcom, INC. | $21.93 | 2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $21.46 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.36 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.14 | 2019 | |
| Cranial Technologies, INC | $15.59 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $15.44 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.46 | 2019 | |
| Merck Sharp & Dohme LLC | $14.20 | 2019 | |
| Strongbridge US INC. | $13.34 | 2020 | |
| Glaxosmithkline, LLC. | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Royster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.